Extraction of diuretics from urine using EVOLUTE® EXPRESS ABN cartridges
By Biotage
Introduction
This procedure is recommended for the extraction of a variety of diuretics from urine using non-polar polymeric SPE. The analyte suite includes thiazides, carbonic anhydrase inhibitors, loop and potassium sparring diuretics, with wide ranging pKa and logP values.
Analytes
Amiloride, Acetazolamide, Hydrochlorothiazide, Methazolamide, Hydroflumethiazide, Furosemide, Bendoflumethiazide, Bumetanide, Spironolactone, Ethacrynic acid.
Sample preparation procedure
Format
EVOLUTE® EXPRESS ABN 100 mg/3 mL (Tables), part number 610-0010-BXG.
Sample
Spike urine sample with at 50 ng/L concentration of the compounds listed above.
Sample pre-treatment
Dilute urine sample (1–2 mL) with 1% formic acid (1:1, v/v).
Cartridge conditioning
Methanol (3 mL).
Cartridge equilibration
0.1% (v/v) formic acid (3 mL).
Sample application
Apply diluted sample.
Interference elution
Rinse with water/methanol (95:5, v/v, 3 mL).
Analyte elution
Methanol (3 mL).
Post-extraction
Evaporate to dryness and reconstitute in water/methanol (50:50, v/v, 1 mL) for subsequent LC-MS/MS analysis.
HPLC conditions
Instrument
Waters 2795 Liquid Handling System (Waters Assoc., Milford, MA, USA).
Column
Zorbax Eclipse XDB C18 3.5 μm analytical column(100 x 2.1 mm ID) (Agilent Technologies, Berkshire, UK).
Guard column
C8 guard column (Agilent Technologies, Berkshire, UK).
Mobile phase
0.1% aqueous formic acid and MeCN at a flow rate of 0.25 mL/min.
Gradient 90%
0.1% aqueous formic acid and 10% (v/v) MeCN at a flow rate of 0.25 mL/min increasing to 90% (v/v) MeCN over 7 minutes. The high concentration organic mobile phase was held for 1 minute then returned to the initial starting conditions.
Injection volume
10 μL.
Temperature
Ambient temperature

Mass spectrometry
Instrument
Ultima Pt triple quadrupole mass spectrometer (Waters Assoc., Manchester, UK) equipped with an electrospray interface for mass analysis. Positive ions were acquired in the multiple reaction monitoring mode (MRM).
Desolvation temperature
350 °C
Ion source temperature:
100 °C
Collision gas pressure
2.9 x 10-3mbar
The base peak in each compound spectrum was attributed to the protonated, [M+H]+ or deprotonated molecular ions [M-H]-and were subsequently used as the precursor ions in the resulting MRM transitions. Positive/negative ion switching was utilized to analyse all the diuretics in this suite. Full MRM transitions and ionization conditions are shown in Table 1.
Figure 1: Recoveries (>80%, <10% RSD, n=5) for diuretics from urine.
Note: This work was originally performed using EVOLUTE® ABN 100 mg/10 mL cartridges.
|
Scan Function |
Analyte |
MRM Transition |
Ionization Polarity |
Cone Voltage (V) |
Collision energy (eV) |
|
1 |
Amiloride |
223.1 > 181.1 |
+ |
35 |
12 |
|
|
Acetazolamide |
230.1 > 189.1 |
+ |
35 |
15 |
|
2 |
Hydrochlorothiazide |
296.1 > 269.0 |
- |
100 |
19 |
|
3 |
Methazolamide |
237.1 > 195.1 |
+ |
35 |
12 |
|
4 |
Hydroflumethiazide |
330.1 > 303.0 |
- |
100 |
19 |
|
5 |
Furosemide |
329.1 > 285.0 |
- |
35 |
15 |
|
6 |
Bendoflumethiazide |
420.1 > 289.1 |
- |
100 |
22 |
|
7 |
Bumetanide |
365.2 > 240.2 |
+ |
35 |
15 |
|
8 |
Spironolactone |
417.2 > 341.2 |
+ |
35 |
14 |
|
9 |
Ethacrynic acid |
301.1 > 243.1 |
- |
35 |
12 |
Results
|
Analyte |
% Recovery |
% RSD |
|
Amiloride |
100 |
1 |
|
Acetazolamide |
94 |
6 |
|
Hydrochlorothiazide |
104 |
1 |
|
Methazolamide |
94 |
5 |
|
Hydroflumethiazide |
100 |
2 |
|
Furosemide |
102 |
5 |
|
Bendoflumethiazide |
94 |
7 |
|
Bumetanide |
87 |
7 |
|
Spironolactone |
80 |
10 |
|
Ethacrynic acid |
91 |
8 |
Ordering information
|
Part Number |
Description |
Quantity |
|
610-0010-BXG
|
EVOLUTE® EXPRESS ABN 100 mg/ 3 mL (Tables) Cartridges |
50 |
Literature Number: AN700